MedTrace Logo

Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis

NCT02579733 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2019-08-14

No results posted yet for this study

Summary

The aim of this study is to determine whether azathioprine is effective for mucosal healing in UC patients who achieved clinical remission by the first course of corticosteroids but not mucosal healing in endoscopy.

Conditions

Interventions

DRUG

Azathioprine

DRUG

Placebo

Sponsors & Collaborators

  • Celltrion

    collaborator INDUSTRY

  • Kyungpook National University Hospital

    lead OTHER

Principal Investigators

  • Eun Soo Kim, MD, PhD · Kyungpook National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2018-12-01
Completion
2018-12-01

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02579733 on ClinicalTrials.gov